Structural basis of spike RBM-specific human antibodies counteracting broad SARS-CoV-2 variants
Description
The decrease of antibody efficacy to mutated SARS-CoV-2 spike RBD explains the breakthrough infections and reinfections by Omicron variants. Here, we analyzed broadly neutralizing antibodies isolated from long-term hospitalized convalescent patients
